参考文献/References:
[1]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.[2]王毅.甲状旁腺激素和25羟维生素D对2型糖尿病患者并发骨质疏松症的影响[J].安徽医药,2018,22(10):1901-1904.[3]蒋晓南,李全忠.2型糖尿病患者血糖波动与骨代谢指标及骨密度的关系[J].山东医药,2021,61(13):17-20,24.[4]Shayganfar A,Ebrahimian S,Masjedi M,et al.A study on bone mass density using dual energy X-ray absorptiometry:Does high body mass index have protective effect on bone density in obese patients?[J].J Res Med Sci,2020,25:4.[5]李定中,乐云敏,顾晓东,等.阿法骨化醇软胶囊治疗2型糖尿病骨质疏松的疗效观察[J].中国药物与临床,2019,19(21):3746-3748.[6]陈芳.碳酸钙D3片联合阿法骨化醇软胶囊治疗2型糖尿病合并骨质疏松的效果观察[J].临床合理用药杂志,2019,12(25):61-62.[7]周婷婷,冯正平.绝经后女性2型糖尿病伴骨质疏松患者骨密度与骨代谢指标的相关性分析[J].中国骨质疏松杂志,2019,25(1):29-32.[8]丁霏,陈彦丽,廖静,等.甲状旁腺素、25-羟维生素D及血清钙磷与原发性骨质疏松症的相关性分析[J].国际检验医学杂志,2020,41(6):648-651.[9]朱静,李娜.血清骨特异性碱性磷酸酶骨钙素甲状旁腺激素抗酒石酸酸性磷酸酶5b检测对老年女性骨质疏松症的诊断分析[J].山西医药杂志,2020,49(15):1993-1995.[10]中华医学会骨质疏松和骨矿盐疾病分会.中国骨质疏松症流行病学调查及“健康骨骼”专项行动结果发布[J].中华骨质疏松和骨矿盐疾病杂志,2019,12(4):317-318.[11]Russow G,Jahn D,Appelt J,et al.Anabolic Therapies in Osteoporosis and Bone Regeneration[J].International Journal of Molecular Sciences,2018,20(1):83.[12]Jaalkhorol M,Fujita Y,Kouda K,et al.Low bone mineral density is associated with an elevated risk of developing increased arterial stiffness: A 10-year follow-up of Japanese women from the Japanese Population-based Osteoporosis (JPOS) cohort study[J].Maturitas,2019,119:39-45.[13]Chen Z,Bemben MG,Bemben DA.Bone and muscle specific circulating microRNAs in postmenopausal women based on osteoporosis and sarcopenia status[J].Bone,2019,120:271-278.[14]杨梅,沈红宇,沈建新,等.40岁以上人群骨密度与血清钙磷代谢、维生素D及骨代谢的相关性研究[J].东南大学学报(医学版),2021,40(1):22-26.[15]Lai EL,Huang WN,Chen HH,et al.Ten-year fracture risk by FRAX and osteoporotic fractures in patients with systemic autoimmune diseases[J].Lupus,2019,28(8):945-953.
相似文献/References:
[1]吴玲,李玉兰.个性化心理护理干预应用于骨质疏松的临床效果观察[J].医学信息,2018,31(01):158.[doi:10.3969/j.issn.1006-1959.2018.01.062]
WU Ling,LI Yu-lan.The Clinical Effect of Personalized Psychological Nursing Intervention on Osteoporosis[J].Journal of Medical Information,2018,31(16):158.[doi:10.3969/j.issn.1006-1959.2018.01.062]
[2]王 忻,赵 毅,朱 悦,等.甲状旁腺激素应用于大鼠脊髓损伤后防治骨质疏松的效果分析[J].医学信息,2018,31(02):54.[doi:10.3969/j.issn.1006-1959.2018.02.019]
WANG Xin,ZHAO Yi,ZHU Yue,et al.Effect of Parathyroid Hormone on Prevention and Treatment of
Osteoporosis after Spinal Cord Injury in Rats[J].Journal of Medical Information,2018,31(16):54.[doi:10.3969/j.issn.1006-1959.2018.02.019]
[3]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in
Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(16):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[4]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(16):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[5]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的
相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(16):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[6]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(16):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[7]刘小花.经皮穿刺椎体成形术治疗老年性骨质疏松性
椎体压缩骨折的疗效分析[J].医学信息,2018,31(05):186.[doi:10.3969/j.issn.1006-1959.2018.05.070]
LIU Xiao-hua.The Effect of Percutaneous Vertebroplasty in the Treatment of Senile Osteoporotic Vertebral Compression Fracture[J].Journal of Medical Information,2018,31(16):186.[doi:10.3969/j.issn.1006-1959.2018.05.070]
[8]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(16):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[9]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行
健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(16):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
[10]丁 星,赵 畅,张海严,等.麦邦数据远程传输型血糖仪临床测量准确性的评价研究[J].医学信息,2018,31(15):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
DING Xing,ZHAO Chang,ZHANG Hai-yan,et al.Evaluation of Accuracy of Clinical Measurement of Maibang Remote Data Transmission Glucometer[J].Journal of Medical Information,2018,31(16):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]